Long-acting injectable antipsychotics in patients with schizophrenia: Systematic review and mixed treatment meta-analysis
Long-acting injectable antipsychotics (LAIs) are recommended for schizophrenic patients who cannot adhere to oral medication. We systematically reviewed randomized controlled trials of 6 LAIs available in Thailand including fluphenazine, flupentixol, haloperidol, zuclopenthixol, paliperidone, and ri...
Saved in:
Main Authors: | Osot Nerapusee, Chanadda Chinthammit, Chavalit Romyen, Maneeporn Pangjunhom, Daniel C. Malone, Rungpetch Sakulbumrungsil |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84962109840&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/44031 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Long-acting injectable antipsychotics in patients with schizophrenia: Systematic review and mixed treatment meta-analysis
by: Osot Nerapusee, et al.
Published: (2018) -
Cannabis Use Correlates with Aggressive Behavior and Long-acting Injectable Antipsychotic Treatment in Asian Patients with Schizophrenia
by: Seon-Cheol Park, et al.
Published: (2019) -
Quetiapine versus typical antipsychotic medications for schizophrenia
by: Sirijit Suttajit, et al.
Published: (2018) -
Quetiapine versus typical antipsychotic medications for schizophrenia
by: Sirijit Suttajit, et al.
Published: (2018) -
Quetiapine versus typical antipsychotic medications for schizophrenia.
by: Suttajit S., et al.
Published: (2014)